Obesity and cancer: A gut microbial connection

Cancer Research

Volumn 74, Issue 7, 2014, Pages 1885-1889

  Ohtani, Naoko ^a   Yoshimoto, Shin ^a   Hara, Eiji ^a  

^a CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYCHOLIC ACID;

CANCER RISK; CELL AGING; CELL AGING, CELL DEGENERATION AND CELL SURVIVAL; DISEASE ASSOCIATION; HUMAN; INTESTINE FLORA; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SENESCENCE ASSOCIATED SECRETORY PHENOTYPE; TUMOR PROMOTION;

ANIMALS; CELL AGING; DEOXYCHOLIC ACID; DNA DAMAGE; HUMANS; INTESTINES; MICE; NEOPLASMS; OBESITY;

EID: 84897438156     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-3501     Document Type: Review

References (47)

1. Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 2011;11:886-95.
2. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-91.
3. Sun B, Karin M. Obesity, inflammation, and liver cancer. J Hepatol 2012;56:704-13.
4. d'Adda di Fagagna F. Living on a break: cellular senescence as a DNAdamage response. Nat Rev Cancer 2008;8:512-22.
5. Kuilman T, Michaloglou C, Mooi W J, Peeper DS. The essence of senescence. Genes Dev 2010;24:2463-79.
6. Ohtani N, Hara E. Cellular senescence: roles and mechanisms of cellular senescence in regulation of tissue homeostasis. Cancer Sci 2013;104:525-30.
7. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005;120:513-22.
8. Collado M, Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 2010;10:51-7.
9. Adams PD. Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol Cell 2009;36:2-14.
10. Copp-e JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, et al. Senescence-Associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008;6:2853-68.
11. Rodier F, Copp-e JP, Patil CK, Hoeijmakers W A, Munoz DP, Raza SR, et al. Persistent DNA damage signalling triggers senescence-Associated inflammatory cytokine secretion. Nat Cell Biol 2009;11:973-79.
12. Takahashi A, Imai Y,Yamakoshi K, Kuninaka S, Ohtani N, Yoshimoto S, et al. DNA damage signaling triggers degradation of histone methyltransferases through APC/CCdh1 in senescent cells. Mol Cell 2012;45: 123-31.
13. Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011;192:547-56.
14. Pribluda A, Elyada E, Wiener Z, Hamza H, Goldstein RE, Biton M, et al. A senescence-inflammatory switch from cancer-inhibitory to cancerpromoting mechanism. Cancer Cell 2013;24:242-56.
15. Lujambio A, Akkari L, Simon J, Grace D, Tschharganeh DF, Bolden JE, et al. Non-cell-Autonomous tumor suppression by p53. Cell 2013; 153:449-60.
16. Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010;140:197-208.
17. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA, et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996;85:27-37.
18. Ohtani N, Imamura Y, Yamakoshi K, Hirota F, Nakayama R, Kubo Y, et al. Visualizing the dynamics of p21Waf1/Cip1 cyclin-dependent kinase inhibitor expression in living animals. Proc Natl Acad Sci USA 2007; 104:15034-39.
19. Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013;499:97-101.
20. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995;92:9363-67.
21. Narita M, Nuñez S, Heard E, Narita M, Lin AW, Hearn SA, et al. Rbmediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003;113:703-16.
22. Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, et al. Senescence-Associated b-galactosidase is lysosomal b-galactosidase. Aging Cell 2006;5:187-95.
23. Di Micco R, Sulli G, Dobreva M, Liontos M, Botrugno OA, Gargiulo G, et al. Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer. Nat Cell Biol 2011;13:292-302.
24. Kosar M, Bartkova J, Hubackova S, Hodny Z, Lukas J, Bartek J, et al. Senescence-Associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type-And insult-dependent manner and follow expression of p16(ink4a). Cell Cycle 2011;10:457-68.
25. Kennedy AL, McBryan T, Enders GH, Johnson FB, Zhang R, Adams PD, et al. Senescent mouse cells fail to overtly regulate the HIRA histone chaperone and do not form robust senescence associated heterochromatin foci. Cell Div 2010;5:16.
26. Orjalo AV, Bhaumik D, Gengler BK, Scott GK, Campisi J. Cell surfacebound IL-1a is an upstream regulator of the senescence-Associated IL-6/IL-8 cytokine network. Proc Natl Acad Sci USA 2009;106: 17031-36.
27. Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 2013;15:978-90.
28. Yang L, Jung Y, Omenetti A, Witek RP, Choi S, Vandongen HM, et al. Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells 2008;26:2104-13.
29. Sato Y, Murase K, Kato J, Kobune M, Sato T, Kawano Y, et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol 2008;26:431-42.
30. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology:human gut microbes associated with obesity. Nature 2006;444:1022-23.
31. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI, et al. An obesity-Associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-31.
32. Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 2012;21:504-16.
33. Payne CM, Weber C, Crowley-Skillicorn C, Dvorak K, Bernstein H, Bernstein C, et al. Deoxycholate induces mitochondrial oxidative stress and activates NF-kB through multiple mechanisms in HCT-116 colon epithelial cells. Carcinogenesis 2007;28:215-22.
34. Kitazawa S, Denda A, Tsutsumi M, Tsujiuchi T, Hasegawa K, Tamura K, et al. Enhanced preneoplastic liver lesion development under selection pressure' conditions after administration of deoxycholic or lithocholic acid in the initiation phase in rats. Carcinogenesis 1990;11:1323-28.
35. Ridlon JM, Hylemon PB. Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7a-dehydroxylating intestinal bacterium. J. Lipid Res 2012;53: 66-76.
36. Calle EE, Rodriguez C, Walker-Thunmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studies cohort of U.S. adults. N Engl J Med 2003;348:162-1638.
37. Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF Jr, et al. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 2004;15:35-43.
38. Møller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994;30A:344-50.
39. Wolk A, Gridley G, Svensson M, Nyr-en O, McLaughlin JK, Fraumeni JF, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001;12:13-21.
40. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008;135: 111-21.
41. Haslam DW, James WPT. Obesity. Lancet 2005;366:1197-1209.
42. Torres DM, Harrison SA. Nonalcholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil. Semin Liver Dis 2012;32:30-8.
43. Rafter JJ, Child P, Anderson AM, Alder R, Eng V, Bruce WR, et al. Cellular toxicity of fecal water depends on diet. Am J Clin Nutr 1987;45:559-63.
44. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2004. doi:10.1038/nature12820.
45. Schnabl B, Purbeck CA, Choi YH, Hagedorn CH, Brenner D. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology 2003;37:653-64.
46. Newell P, Toffanin S, Villanueva A, Chiang DY, Minguez B, Cabellos L, et al. Ras pathway activation in hepatocellular carcinoma and antitumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol 2009;51:725-33.
47. McGarr SE, Ridlon JM, Hylemon PB. Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. J Clin Gastroenterol 2005;39:98-109.